F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
NCT06789562 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 54
Last updated 2025-01-23
Summary
Is to compare F-18 FDG PET/CT to routine CT in staging of non-small lung cancer and effect on change management.
Conditions
Interventions
- DEVICE
-
F-18FDG PET/CT and CT
compare F-18 FDG PET/CT to routine CT in staging of non-small lung cancer and effect on change management.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-30
- Primary Completion
- 2027-11-30
- Completion
- 2027-12-31
More Related Trials
-
Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer
NCT02664792 ·Status: COMPLETED ·Phase: NA
-
Added Value of PET/CT in Lung Cancer
NCT06494800 ·Status: NOT_YET_RECRUITING
-
To Evaluate the Impact of PET/CT on Radiation Treatment Planning in Relation to Changes in GTV in Stage 3 NSCLC
NCT01888692 ·Status: TERMINATED
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
NCT00424138 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients
NCT02016872 ·Status: COMPLETED ·Phase: NA
-
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
NCT02751710 ·Status: COMPLETED ·Phase: NA
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
PET/MR Imaging in Lung Cancer
NCT03739281 ·Status: TERMINATED ·Phase: NA
-
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
NCT02938546 ·Status: UNKNOWN ·Phase: PHASE3
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
NCT00765986 ·Status: UNKNOWN
-
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
NCT07301801 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
NCT04726215 ·Status: UNKNOWN ·Phase: PHASE2
-
Imaging NSCLC Treatment Response to Immunotherapy
NCT02753569 ·Status: COMPLETED
-
Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma
NCT06737835 ·Status: NOT_YET_RECRUITING
-
PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer
NCT02063633 ·Status: UNKNOWN
-
Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer
NCT01507428 ·Status: COMPLETED ·Phase: PHASE2
-
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
NCT03493789 ·Status: COMPLETED ·Phase: PHASE1
-
MRI Optimization Study in Stage III NSCLC
NCT02076282 ·Status: UNKNOWN
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
NCT06107374 ·Status: RECRUITING ·Phase: PHASE2
-
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
NCT06168877 ·Status: COMPLETED
-
Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)
NCT00136864 ·Status: COMPLETED ·Phase: PHASE3